Interferon beta in the treatment of multiple sclerosis--closing remarks.
Kappos
L
L
Department of Neurology, University of Basle, Kantonsspital Basel, Switzerland.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000628:therapy*
D000276:Adjuvants, Immunologic; D016899:Interferon-beta